Membrane and cytosol fractions from hepatocytes of both normal and streptozotocin-induced diabetic animals were probed with a panel of polyclonal anti-peptide antisera in order to identify protein kinase C (PKC) isoforms. Immunoreactive species were noted with antisera specific for ~ (-81 kDa), fl-ll (-82 kDA), E (--95 kDa) and ~" (~ 79 kDa). In addition, a species migrating with an apparent size of -94 kDa was also detected in cytosol fractions using an antiserum specific for PKC-c~. Each of these species was specifically displaced when the PKC-isoform specific peptide was included in the immunodetection system. No immunoreactive species consistent with the presence of the fl-I, 7, ~ and 1/isoforms of protein kinase C was observed. Induction of diabetes using streptozotocin invoked selective alterations in the expression of PKC isoforms which were reversed upon insulin therapy. In the cytosol fraction, marked increases of ~ 3-fold occurred in levels of the fl-I1 isoform and the ~ 90 kDa (upper) form of PKC-~, with no apparent/little change in the levels of the -81 kDa (lower) form of PKC-cc and those of PKC-~'. Diabetes induction also appeared to have elicited the translocation of PKC-fl-II and the -81 kDa (lower) form of PKC-c~ to the membrane fraction where immunoreactivity for these species was now apparent. The level of PKC-e, which was noted only in membrane fractions, was also increased upon induction of diabetes. It is suggested that the selective alterations in the expression of PKC isoforms occurring upon streptozotocin-induced diabetes may lead to altered cellular functioning and underly defects in inhibitory G-protein functioning and insulin action which characterise this animal model of diabetes.